Keywords: Type 1 Diabetes , T1D Risk , T1D Familial Risk , Type 1 Diabetes Autoantibodies
IRB Number: 00013287
Specialty: Endocrinology and Metabolism, Endocrinology and Metabolism, Pediatric Endocrinology and Metabolism
Sub Specialties: Diabetes, Type 1 Diabetes and Intensive Insulin Therapy,
The overall objective of this study is to perform baseline and repeat assessments over time of the metabolic and immunologic status of individuals at risk for type 1 diabetes (T1D).
· To characterize their risk for developing T1D
· To describe the pathogenetic evolution of T1D and
· To increase the understanding of the pathogenetic factors involved in the development of T1D
The primary study outcome is T1D as defined by the American Diabetes Association (ADA).